Maxcyte, Inc.
MXCTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Maxcyte, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Vanguard Personalized Indexing Management, LLC | 2026-03-31 | 18,793 | $13.2K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 22,085 | $15.5K | SEC filing |
| Abel Hall, LLC | 2026-03-31 | 12,110 | $8.51K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 3,347 | $2.35K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 1,159,019 | $814K | SEC filing |
| ProShare Advisors LLC | 2026-03-31 | 14,660 | $10.3K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 163,062 | $115K | SEC filing |
| FMR LLC | 2026-03-31 | 190,126 | $134K | SEC filing |
| CABOT WEALTH MANAGEMENT INC | 2026-03-31 | 88,623 | $62.3K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 510 | $379 | SEC filing |
| UBS Group AG | 2026-03-31 | 271,054 | $191K | SEC filing |
| Willis Investment Counsel | 2026-03-31 | 862,758 | $606K | SEC filing |
| Wealth Preservation Advisors, LLC | 2026-03-31 | 156 | $110 | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 43,059 | $30.2K | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 20,569 | $14.5K | SEC filing |
| Mink Brook Asset Management LLC | 2026-03-31 | 284,024 | $200K | SEC filing |
| True Wealth Design, LLC | 2026-03-31 | 139 | $98 | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 333,088 | $234K | SEC filing |
| VICTORY CAPITAL MANAGEMENT INC | 2026-03-31 | 11,283 | $7.93K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 606 | $426 | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Maxcyte, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-11-01 · Erck Stanley C: Larger than 54 of the 55 other insider sales of Common Stock on file. SEC filing
- 2024-09-04 · Erck Stanley C: Larger than 52 of the 55 other insider sales of Common Stock on file. SEC filing
- 2024-06-20 · Ross Thomas M.: Larger than 53 of the 55 other insider sales of Common Stock on file. SEC filing
- 2023-12-05 · Doerfler Douglas: Larger than all 55 other insider sales of Common Stock on file. SEC filing
- 2023-06-14 · Doerfler Douglas: Larger than 51 of the 55 other insider sales of Common Stock on file. SEC filing
- 2023-04-06 · Doerfler Douglas: Larger than 50 of the 55 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-17 | Swirsky Douglas J · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −10,142 | 0.82 | SEC filing |
| 2025-08-13 | DOUGLAS RICHARD · Director | Common Stock | P — Open market or private purchase | +80,000 | 1.39 | SEC filing |
| 2025-08-13 | Swirsky Douglas J · CHIEF FINANCIAL OFFICER | Common Stock | P — Open market or private purchase | +50,000 | 1.29 | SEC filing |
| 2025-08-13 | Erck Stanley C · Director | Common Stock | P — Open market or private purchase | +100,000 | 1.37 | SEC filing |
| 2025-08-13 | Brooke William W · Director | Common Stock | P — Open market or private purchase | +50,000 | 1.29 | SEC filing |
| 2025-08-13 | Masoud Maher · President and CEO | Common Stock | P — Open market or private purchase | +75,000 | 1.37 | SEC filing |
| 2025-06-25 | Hemrajani Rekha · Director | Common Stock | S — Open market or private sale | −10,684 | 2.09 | SEC filing |
| 2025-03-18 | Sandoval David I. · GENERAL COUNSEL | Common Stock | S — Open market or private sale | −353 | 3.18 | SEC filing |
Showing 8 of 17 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | Erck Stanley C · Director | Common Stock | A — Grant, award, or other acquisition | +30,421 | SEC filing |
| 2026-06-17 | Johnston John Joseph · Director | Common Stock | A — Grant, award, or other acquisition | +30,421 | SEC filing |
| 2026-06-17 | Collins Cynthia · Director | Common Stock | A — Grant, award, or other acquisition | +30,421 | SEC filing |
| 2026-06-17 | Erck Stanley C · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +49,579 | SEC filing |
| 2026-06-17 | BALTHROP PATRICK J · Director | Common Stock | A — Grant, award, or other acquisition | +30,421 | SEC filing |
| 2026-06-17 | BALTHROP PATRICK J · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +49,579 | SEC filing |
| 2026-06-17 | Johnston John Joseph · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +49,579 | SEC filing |
| 2026-06-17 | Hemrajani Rekha · Director | Common Stock | A — Grant, award, or other acquisition | +30,421 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.